Dr. Lansberg completed his neurology training at the University of California San Francisco (UCSF) and his neurovascular fellowship at Stanford University. Following fellowship, he joined the faculty of the School of Medicine at Stanford where he is currently a Professor of Neurology.

His research interest is in the design and conduct of clinical trials to test new methods for diagnosing and treating stroke patients. He has been an investigator on dozens of stroke trials. The primary focus of his research has been on the use of modern imaging techniques for the evaluation of acute stroke. These techniques include diffusion-weighted MRI, perfusion-weighted MRI and CT perfusion.

Dr. Lansberg played a lead role in the recently completed DEFUSE 3 trial, which demonstrated that patients selected with MR or CT perfusion imaging benefit from endovascular stroke therapy up to 16 hours after onset. He is also an investigator on several stroke prevention and recovery trials.